U.S. market Closed. Opens in 11 hours 26 minutes

INDP | Indaptus Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312021-03-212020-12-312019-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue1.28K1.78K1.40KN/A852.00854.00K
Gross Profit-1.28K-1.78K-1.40KN/A-852.00-854.00K
Operating Expenses16.38M14.91M7.73M7.73M3.60M34.09M
Selling, General & Admin8.76M8.59M5.21M5.21M944.25K7.43M
Research & Development7.62M6.32M2.52M2.52M2.66M26.66M
Other Operating Expenses7.62MN/AN/AN/AN/AN/A
Operating Income-16.38M-14.91M-7.73M-7.73M-3.60M-34.95M
Other Expenses / Income955.00K588.11K17.72K17.72K15.11K-12.02M
Before Tax Income-15.42M-14.32M-7.71M-7.71M-3.58M-46.96M
Income Tax Expenses-16.38M-588.11K-17.72KN/A-15.11K638.00K
Net Income-15.42M-13.73M-7.69M-7.71M-3.57M-47.60M
Interest ExpensesN/A588.11KN/AN/AN/A15.00K
Basic Shares Outstanding8.40M8.26M4.09M8.19M486.17K422.20K
Diluted Shares Outstanding8.40M8.26M4.09M8.19M486.17K422.20K
EBITDA-16.38M-14.91M-7.73MN/A-3.60M-34.09M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-31.80M-13.73M-7.71M-7.71M-3.58M-46.95M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312021-03-212020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙